Corroborating our findings in mESCs, differential expression of other MMR genes (such as MLH3, MSH2, and PMS2) had no effect on overall survival of breast cancer patients (Supplemental Figure 3, C–E). This evidence concerns the gene MLH3 and breast cancer.